Yurpeak 5mg Injection contains tirzepatide, a prescription medicine used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus and to support chronic weight management in adults with obesity or overweight who have at least one weight‑related comorbidity. Tirzepatide works as a dual agonist on glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) receptors, helping control blood sugar levels and reduce appetite to support weight loss and improved metabolic health. Your doctor will explain why it is suitable for you.

Yurpeak 5mg Injection is administered as a subcutaneous injection once weekly under the skin of the abdomen, thigh, or upper arm, usually on the same day each week. Your doctor or healthcare provider will show you how to use the pre‑filled pen and decide the correct schedule and dose based on your condition and response. Do not self‑administer without training.

Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, and headache. These symptoms are generally mild and often improve as your body adjusts to the medicine. Serious side effects can occur, including signs of low blood sugar when used with other glucose‑lowering medicines, symptoms of pancreatitis such as severe abdominal pain, or allergic reactions. Contact your doctor immediately if you notice symptoms such as severe abdominal pain, persistent vomiting, difficulty breathing, or signs of a serious allergic reaction.

You can obtain Yurpeak 5mg Injection from licensed pharmacies with a valid prescription. Contact Macarius Health to check availability and pricing.

Store Yurpeak 5mg Injection in a refrigerator at 2°C to 8°C. Do not freeze. Keep the medicine in its original packaging and out of reach of children and pets. Protect it from direct heat and sunlight.

Tell your doctor about all other medicines, supplements, or herbal products you are taking. Some medicines, particularly other glucose‑lowering therapies, may interact with tirzepatide and increase the risk of low blood sugar or other side effects. Your doctor may adjust your treatment or monitoring accordingly.

Yurpeak 5mg Injection is not recommended during pregnancy or while breastfeeding as its effects on the unborn baby or infant are unknown. If you are pregnant, planning pregnancy, or breastfeeding, discuss any concerns with your doctor before starting this medicine.

Delivery time depends on stock availability and location. Macarius Health arranges prompt delivery within Delhi NCR. For other cities across India, delivery typically follows standard courier timelines.